C22orf23

gene
On this page

Also known as FLJ32787EVG1LOC84645

Summary

C22orf23 (chromosome 22 open reading frame 23, HGNC:18589) is a protein-coding gene on chromosome 22q13.1, encoding UPF0193 protein EVG1 (Q9BZE7).

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 7 total
  • MANE Select transcript: NM_032561

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18589
Approved symbolC22orf23
Namechromosome 22 open reading frame 23
Location22q13.1
Locus typegene with protein product
StatusApproved
AliasesFLJ32787, EVG1, LOC84645
Ensembl geneENSG00000128346
Ensembl biotypeprotein_coding
OMIM619678
Entrez84645

Gene structure

Transcript identifiers

Ensembl transcripts: 15 — 15 protein_coding

ENST00000249079, ENST00000403026, ENST00000403305, ENST00000418863, ENST00000422191, ENST00000619227, ENST00000856379, ENST00000856380, ENST00000856381, ENST00000856382, ENST00000856383, ENST00000856384, ENST00000856385, ENST00000955708, ENST00000955709

RefSeq mRNA: 2 — MANE Select: NM_032561 NM_001207062, NM_032561

CCDS: CCDS13962, CCDS74860

Canonical transcript exons

ENST00000403305 — 7 exons

ExonStartEnd
ENSE000008802403794441737944517
ENSE000008802413794504237945173
ENSE000008802423794728137947463
ENSE000008802433795146037951522
ENSE000008802443795304737953158
ENSE000015610923795344837953601
ENSE000037260243794305037944246

Expression profiles

Bgee: expression breadth ubiquitous, 167 present calls, max score 96.09.

FANTOM5 (CAGE): breadth broad, TPM avg 1.5545 / max 738.8772, expressed in 431 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1940991.5545431

Top tissues by expression

257 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453396.09gold quality
spermCL:000001996.04gold quality
right testisUBERON:000453495.39gold quality
testisUBERON:000047393.23gold quality
adult organismUBERON:000702389.31gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047388.37gold quality
right uterine tubeUBERON:000130287.62gold quality
smooth muscle tissueUBERON:000113587.20gold quality
muscle layer of sigmoid colonUBERON:003580586.68gold quality
body of stomachUBERON:000116186.32gold quality
C1 segment of cervical spinal cordUBERON:000646985.07gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.33gold quality
bronchial epithelial cellCL:000232883.57gold quality
lower esophagusUBERON:001347382.48gold quality
lower esophagus muscularis layerUBERON:003583382.43gold quality
stomachUBERON:000094582.20gold quality
bronchusUBERON:000218581.85gold quality
cortical plateUBERON:000534381.66gold quality
olfactory segment of nasal mucosaUBERON:000538681.44gold quality
spinal cordUBERON:000224081.02gold quality
body of uterusUBERON:000985380.81gold quality
skin of legUBERON:000151180.06gold quality
esophagogastric junction muscularis propriaUBERON:003584180.00gold quality
left uterine tubeUBERON:000130379.78gold quality
esophagusUBERON:000104379.52gold quality
skin of abdomenUBERON:000141679.04gold quality
lower esophagus mucosaUBERON:003583478.59gold quality
ectocervixUBERON:001224978.50gold quality
stromal cell of endometriumCL:000225578.32gold quality
fundus of stomachUBERON:000116078.26gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.80

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

33 targeting C22orf23, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-570-3P99.9672.414910
HSA-MIR-464899.9167.00710
HSA-MIR-449299.8768.253611
HSA-MIR-430799.8270.453374
HSA-MIR-378G99.7164.901106
HSA-MIR-6762-3P99.6666.941188
HSA-MIR-6836-5P99.6065.621538
HSA-MIR-613299.6065.831554
HSA-MIR-1207-5P99.4969.112983
HSA-MIR-365A-3P99.4370.02836
HSA-MIR-365B-3P99.4370.02836
HSA-MIR-3140-5P99.3969.041136
HSA-MIR-3678-3P99.3167.101432
HSA-MIR-664A-3P99.2271.082696
HSA-MIR-892C-5P99.1670.562116
HSA-MIR-4763-3P99.1067.832649
HSA-MIR-66199.0965.942062
HSA-MIR-6769B-5P98.7364.911092
HSA-MIR-2467-3P98.6567.181969
HSA-MIR-7114-3P98.4266.53569
HSA-MIR-428998.2666.90810
HSA-MIR-1180-5P98.1665.32460
HSA-MIR-6769A-5P97.9964.16851
HSA-MIR-4700-3P97.7468.641014
HSA-MIR-3187-3P97.3865.80904
HSA-MIR-311697.0765.781324
HSA-MIR-3194-5P96.8064.901027
HSA-MIR-4727-3P96.7564.97415
HSA-MIR-2276-5P96.2765.85937
HSA-MIR-443595.9065.471201

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriosi:dkey-43k4.3ENSDARG00000052428
mus_musculus1700088E04RikENSMUSG00000033029
rattus_norvegicusC7h22orf23ENSRNOG00000011170
drosophila_melanogasterCG5280FBGN0035952

Protein

Protein identifiers

UPF0193 protein EVG1Q9BZE7 (reviewed: Q9BZE7)

All UniProt accessions (4): Q9BZE7, A0A087X0J6, B0QYM1, B0QYM2

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the UPF0193 (EVG1) family.

RefSeq proteins (2): NP_001193991, NP_115950* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007914UPF0193Family

Pfam: PF05250

UniProt features (3 total): chain 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BZE7-F180.780.43

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 40 (showing top): GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, chr22q13, SCGGAAGY_ELK1_02, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CHENG_IMPRINTED_BY_ESTRADIOL, MODULE_49, BRUINS_UVC_RESPONSE_LATE, ELF2_TARGET_GENES, RFX7_TARGET_GENES, TEAD2_TARGET_GENES, MIR570_3P, MIR4307, MIR2467_3P, MIR3140_5P, MIR4435

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1

Protein interactions and networks

STRING

336 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
C22orf23TSACCQ96A04661
C22orf23CCDC54Q8NEL0592
C22orf23GARIN1BQ96KD3571
C22orf23ODAD4Q96NG3570
C22orf23CATSPERTQ53TS8540
C22orf23GKAP1Q5VSY0507
C22orf23ACTRT2Q8TDY3507
C22orf23CXorf65A6NEN9479
C22orf23CCDC187A0A096LP49478
C22orf23C20orf173Q96LM9478
C22orf23CAPZA3Q96KX2476
C22orf23TMCO2Q7Z6W1475
C22orf23RIMBP3Q9UFD9471
C22orf23ZC3H11DQ8NA57447
C22orf23FAM209AQ5JX71447

IntAct

16 interactions, top by confidence:

ABTypeScore
CCNDBP1C22orf23psi-mi:“MI:0915”(physical association)0.670
C22orf23CCNDBP1psi-mi:“MI:0915”(physical association)0.670
C22orf23VPS28psi-mi:“MI:0915”(physical association)0.590
C1orf74C22orf23psi-mi:“MI:0915”(physical association)0.560
ESRRGC22orf23psi-mi:“MI:0915”(physical association)0.560
C22orf23psi-mi:“MI:0915”(physical association)0.370
C22orf23BTBD1psi-mi:“MI:0914”(association)0.350
C1orf74C22orf23psi-mi:“MI:0915”(physical association)0.000
ESRRGC22orf23psi-mi:“MI:0915”(physical association)0.000

BioGRID (10): C22orf23 (Two-hybrid), VPS28 (Affinity Capture-MS), VPS28 (Affinity Capture-MS), C1orf74 (Two-hybrid), ESRRG (Two-hybrid), VPS28 (Affinity Capture-MS), CPVL (Affinity Capture-MS), RBM12 (Affinity Capture-MS), BTBD1 (Affinity Capture-MS), VIM (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0A1B0GU71, A6QPI4, B2RV13, D4A6L0, E1BBQ2, F1LQY6, G3UW36, O08856, P15382, P53801, P55199, P56182, Q08CB3, Q0VF94, Q148E1, Q17RQ9, Q2KJ58, Q32Q90, Q4R5F9, Q4V8A6, Q4VA36, Q5I0I4, Q5NVI6, Q5R8Q2, Q5T6X4, Q5T848, Q5XII8, Q68EN5, Q6P767, Q8C419, Q8CHT6, Q8R143, Q8R1T1, Q8TBN0, Q8VDV3, Q8WUX9, Q90YH8, Q91WM6, Q91ZP9, Q96IL0

Diamond homologs: Q9BZE7, Q9D9S1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

7 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance2
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1363 predictions. Top by Δscore:

VariantEffectΔscore
22:37944411:TCCTA:Tdonor_loss1.0000
22:37944412:CCTAC:Cdonor_loss1.0000
22:37944413:CTA:Cdonor_loss1.0000
22:37944414:TACCT:Tdonor_loss1.0000
22:37944415:ACC:Adonor_loss1.0000
22:37944513:CACCA:Cacceptor_gain1.0000
22:37944515:CCA:Cacceptor_gain1.0000
22:37944516:C:CTacceptor_gain1.0000
22:37944516:CA:Cacceptor_gain1.0000
22:37944517:AC:Aacceptor_loss1.0000
22:37944518:C:CCacceptor_gain1.0000
22:37944518:C:Tacceptor_loss1.0000
22:37944519:T:Gacceptor_loss1.0000
22:37945038:TTAC:Tdonor_loss1.0000
22:37945039:T:TGdonor_loss1.0000
22:37945040:A:ACdonor_gain1.0000
22:37945040:A:ATdonor_loss1.0000
22:37945040:ACG:Adonor_gain1.0000
22:37945040:ACGCT:Adonor_gain1.0000
22:37945041:C:CCdonor_gain1.0000
22:37945041:C:CTdonor_loss1.0000
22:37945041:CG:Cdonor_gain1.0000
22:37945041:CGC:Cdonor_gain1.0000
22:37945041:CGCT:Cdonor_gain1.0000
22:37945041:CGCTC:Cdonor_gain1.0000
22:37945169:ATCCC:Aacceptor_gain1.0000
22:37945170:TCCC:Tacceptor_gain1.0000
22:37945171:CCC:Cacceptor_gain1.0000
22:37945171:CCCC:Cacceptor_gain1.0000
22:37945172:CC:Cacceptor_gain1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000200815 (22:37945452 C>T), RS1000325209 (22:37948461 A>G), RS1000804798 (22:37947573 C>T), RS1000979069 (22:37943561 G>A), RS1001032659 (22:37943915 C>G), RS1001358582 (22:37949787 C>T), RS1001625682 (22:37946612 G>A,C,T), RS1001912035 (22:37954547 C>T), RS1001914878 (22:37948150 T>C), RS1002259884 (22:37954800 C>T), RS1003031294 (22:37949900 A>G), RS1003083638 (22:37949748 C>A,T), RS1003556247 (22:37942656 G>A), RS1003872821 (22:37945936 A>G,T), RS1003903577 (22:37945638 G>A)

Disease associations

OMIM: gene MIM:619678 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST007327_30Smoking status (ever vs never smokers)3.000000e-08

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004318smoking behavior

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

12 total (human), top 12 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
di-n-butylphosphoric acidaffects expression1
nutlin 3increases expression1
jinfukangaffects cotreatment, increases expression1
Sunitinibdecreases expression1
Acetaminophenincreases expression1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Camptothecinincreases expression1
Cisplatinaffects cotreatment, increases expression1
Smokeincreases abundance, increases expression1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.